10/31/2024
3:42 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:00 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
8:08 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
8:10 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:04 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:13 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
5:10 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/24/2024
4:31 PM | Coya Therapeutics (Filer)
| Form 424B3 | |
06/23/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
7:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 PM | Berman Howard (Reporting)
Coya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:00 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:20 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
4:21 PM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:40 PM | Coya Therapeutics (Filer)
| Form ARS | |
03/28/2024
3:30 PM | Coya Therapeutics (Filer)
| Form DEF 14A | |
03/28/2024
3:35 PM | Coya Therapeutics (Filer)
| Form DEFA14A | |
03/19/2024
7:21 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:27 AM | Coya Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:00 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:46 PM | Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
| Form SC 13G/A | |
02/07/2024
5:55 PM | Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
7:00 PM | Berman Howard (Reporting)
Coya Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:00 PM | Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Lee Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:30 PM | Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
7:15 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2024
11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
01/04/2024
3:46 PM | Coya Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:05 PM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
7:00 AM | Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2023
8:46 AM | Coya Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/20/2023
7:35 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
6:30 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
8:03 AM | Coya Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
8:07 AM | Coya Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
